临床外科杂志 ›› 2026, Vol. 34 ›› Issue (7): 757-762.doi: 10.3969/j.issn.1005-6483.20250984

• 论著 • 上一篇    下一篇

原发性肝癌并发肌肉减少症的危险因素分析及对病人预后的影响

卢冀超,苏淼,董曼   

  1. 053000 河北衡水,衡水市人民医院消化内科
  • 收稿日期:2025-10-15 出版日期:2026-07-20 发布日期:2026-07-20
  • 基金资助:
    河北省2023年度医学科学研究项目(20232171)

Analysis of risk factors for sarcopenia in patients with primary liver cancer and its impact on prognosis

LU Jichao, SU Miao, DONG Man   

  1. Department of Gastroenterology, Hengshui People's Hospital, Hebei, Hengshui 053000, China
  • Received:2025-10-15 Online:2026-07-20 Published:2026-07-20

摘要: 目的 分析原发性肝癌并发肌肉减少症的危险因素及对病人预后的影响。方法 2017年11月~2019年6月收治的原发性肝癌病人112例,根据病人否合并肌肉减少症分为肌肉减少症组(33例)和非肌肉减少症组(79例)。采用多因素Logistic回归分析影响原发性肝癌并发肌肉减少症的相关因素;所有病人均随访5年,采用Kaplan-Meier法绘制生存曲线,比较两组的5年生存率。结果 112例原发性肝癌病人肌肉减少症发生率为29.46%。肌肉减少症组病人年龄≥60岁占比、吸烟史占比、饮酒史占比、合并基础疾病占比、营养风险筛查( NRS )2002≥3分占比、肿瘤分期Ⅲ~Ⅳ期占比、Child-Pugh分级B级占比均高于非肌肉减少症组,身体质量指数(BMI)、白蛋白水平均低于非肌肉减少症组,两组比较差异有统计学意义(P<0.05),另外骨骼肌质量指数在两组间存在显著差异,且该差异在按性别分层后仍然显著(P<0.05)。多因素Logistic回归分析显示,年龄≥60岁(OR=1.941)、Child-Pugh分级B级(OR=2.683)、NRS 2002≥3分(OR=3.404)均是影响原发性肝癌并发肌肉减少症的危险因素(P<0.05),BMI是其保护因素(OR=0.296,P<0.05)。Kaplan-Meier生存分析及Log-rank检验表明,肌肉减少症组的中位生存时间为36.5个月(95%CI:28.4~44.6),低于非肌少症组58.0个月(95%CI:49.1~66.9),两组比较差异有统计学意义(P<0.05)。肌肉减少症组和非肌肉减少症组5年生存率分别为24.24% 和 44.30%,两组比较差异有统计学意义(χ2=3.961,P<0.05)。单因素分析显示,除肌肉减少症外,年龄≥60岁、较低的BMI、肿瘤分期Ⅲ~Ⅳ期及Child-Pugh B级也与总生存期显著相关(P<0.05)。多因素Cox回归分析显示,肌肉减少症(HR=2.861)、BMI降低(HR=1.268)、年龄≥60岁(HR=1.727)、肿瘤分期Ⅲ~Ⅳ期(HR=1.980)、Child-Pugh B级(HR=2.119)为总生存期的危险因素(P<0.05)。结论 肌肉减少症在原发性肝癌病人中发生率高,其发生与年龄、营养状况及肝功能等因素有关,且其存在是导致病人总生存期缩短的独立危险因素。

关键词: 原发性肝癌, 肌肉减少症, 危险因素, 预后

Abstract: Objective To analyze the risk factors of primary liver cancer complicated with sarcopenia and its impact on the prognosis of patients.Methods A retrospective analysis was conducted on the clinical data of 112 patients with primary liver cancer who were hospitalized in our hospital from November 2017 to June 2019.The patients were divided into the sarcopenia group(33 cases) and the non-sarcopenia group(79 cases) according to whether they were complicated with sarcopenia.The related factors affecting the occurrence of sarcopenia in primary liver cancer were evaluated by Multivariate Logistic regression.All subjects were followed up for 5 years, and the survival curves were plotted using the Kaplan-Meier method to compare the 5-year survival rates among the groups.Results The incidence of sarcopenia in 112 patients with primary liver cancer was 29.46%.The proportions of patients aged ≥ 60 years, smoking history, drinking history, combined underlying diseases, NRS 2002 score ≥3, tumor stage Ⅲ-Ⅳ, and Child-Pugh grade B in the sarcopenia group were all higher than those in the non-sarcopenia group, while the body mass index and albumin level were lower than those in the non-sarcopenia group (P<0.05).In addition, there was a significant difference in skeletal muscle mass index between the two groups, and this difference remained significant even after stratification by gender (P<0.05).Multivariate analysis showed that age ≥60 years (OR=1.941), Child-Pugh grade B (OR=2.683), and nutrition risk screening 2002(NRS2002) score ≥3 (OR=3.404) were all risk factors affecting sarcopenia in primary liver cancer (P<0.05).BMI (OR=0.296) was a protective factor (P<0.05).Kaplan-Meier survival analysis and Log-rank test showed that the median survival time in the sarcopenia group was 36.5 months (95%CI: 28.4-44.6), which was lower than 58.0 months (95%CI: 49.1-66.9) in the non-sarcopenia group.There was a statistically significant difference between the two groups (P<0.05).The 5-year survival rate was also significantly lower (24.24% vs.44.30%), and the Log-rank test for comparing the survival curves of the two groups showed statistically significant differences (χ2=3.961, P<0.05).Univariate analysis showed that, in addition to sarcopenia, age ≥60 years old, lower body mass index, tumor stage Ⅲ-Ⅳ and Child-Pugh grade B were also significantly associated with overall survival (P<0.05).The final model of multivariate Cox regression analysis shows that Sarcopenia (HR=2.861), decreased body mass index (HR=1.268), age ≥60 years old (HR=1.727), tumor stage Ⅲ-Ⅳ (HR=1.980), and Child-Pugh grade B (HR=2.119) were risk factors for overall survival (P<0.05).Conclusion Sarcopenia has a high incidence among patients with primary liver cancer.Its occurrence is related to factors such as age, nutritional status and liver function, and its existence is an independent risk factor for shortening the overall survival period of patients.

Key words: primary liver cancer, sarcopenia, risk factors, prognosis

[1] 武政, 薛小伟, 刘向栋. 骨质疏松椎体压缩性骨折经皮椎体成形术术后牵涉痛发生情况及危险因素分析[J]. 临床外科杂志, 2026, 34(7): 814-818.
[2] 余晶晶, 诸葛恒艳, 王娟, 许科峰, 吴琳. 老年骨质疏松性脊柱骨折病人椎体强化术后再骨折的危险因素分析[J]. 临床外科杂志, 2026, 34(7): 827-831.
[3] 蒋百露, 赵云, 于华明, 毛冬梅, 熊国江. 多发性肋骨骨折并发血胸的列线图预测模型构建与验证[J]. 临床外科杂志, 2026, 34(7): 834-840.
[4] 叶春祥,王振军. AJCC第九版结肠癌TNM分期系统(建议版)更新要点解读[J]. 临床外科杂志, 2026, 34(6): 622-626.
[5] 任海锋,张三红,杜磊,吴明君,党苗苗. 肺癌组织USP10、USP28和USP35表达及其与临床病理特征和预后的关系[J]. 临床外科杂志, 2026, 34(6): 653-657.
[6] 张志波. 胆道闭锁术后胆汁湖的处理[J]. 临床外科杂志, 2026, 34(5): 486-489.
[7] 黄乐怡 彭宇明 尹强. 胆道闭锁患儿肝移植术后门静脉狭窄的危险因素分析及防治策略[J]. 临床外科杂志, 2026, 34(5): 495-498.
[8] 刘梓涛 陈梦荷 彭湃 沈浩元 胡超华. 趋化因子受体4及基质细胞衍生因子1在三阴性乳腺癌组织中的表达及意义[J]. 临床外科杂志, 2026, 34(5): 506-511.
[9] 赵浩男 王嘉敏 金若天. 血清C-X-C趋化因子受体7和溶质载体家族7成员11与胃癌临床病理特征及病人预后的关系[J]. 临床外科杂志, 2026, 34(5): 518-522.
[10] 张帅 廖德祥 程盛 马丹丹 傅涛. 腹部手术后手术部位感染的相关危险因素分析[J]. 临床外科杂志, 2026, 34(5): 544-549.
[11] 侯文 于洪霞 潘雨婷 段佳丽 云红. 年轻结直肠癌腹膜转移病人行细胞减灭术联合腹腔热灌注化疗的有效性分析[J]. 临床外科杂志, 2026, 34(5): 550-555.
[12] 阮月璐 黄林飞 朱磊 刘倩 刘健. 结直肠癌原发灶中范可尼蛋白表达与术后早期复发转移的关系[J]. 临床外科杂志, 2026, 34(5): 562-566.
[13] 徐跻京 李家轩 曹荣华 黄永高. 肺腺癌气腔播散对肺叶切除术与亚肺叶切除术选择及术后生存转归的影响[J]. 临床外科杂志, 2026, 34(4): 407-411.
[14] 赵庆楠 何代玉 孙笑尘 金丽军. 甲状腺激素应答蛋白Spot 14、尿激酶型纤溶酶原激活物、E26转录因子变异体4与甲状腺乳头状癌颈部淋巴结转移的相关性及预后评估价值[J]. 临床外科杂志, 2026, 34(3): 272-276.
[15] 夏海水 房晓芳 王伟 马上. 血清单酰基甘油酯酶、甘油三磷酸脱氢酶1和人循环前胃泌素表达水平与乳腺癌病人分子分型及预后的关系[J]. 临床外科杂志, 2026, 34(3): 281-285.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!